J&J, startup Alector target Alzheimer's in early-stage research deal
A unit of pharma giant Johnson & Johnson will fund preclinical research by biotech startup Alector LLC into a potential treatment for Alzheimer's disease.
Buzz Stocks: MasterCard Inc, Johnson & Johnson, The Coca-Cola Company, and AT&T Inc.
The major market indexes are churning around breakeven this morning, with traders awaiting a speech from Chicago Fed President Charles Evans early this afternoon.
Military Suicides Not Caused By Pharma Drugs Say Pharma-funded Military Consultants
It took academic, government and military researchers five years to say they don't really know what is causing military suicides but whatever it is--it isn't the psychoactive drugs they are prescribing and pushing.
Who's Afraid of Formaldehyde?
Formaldehyde occurs naturally in common fruits and vegetables . "Unless people calling for removal of quaternium-15 are also keeping their children from eating apples and french fries," Hartings says, "I think their activism might be misplaced."
Texas Medical Center courting Johnson & Johnson incubator
Texas Medical Center is in talks with one of the biggest biomedical research and development incubators about opening a Houston office.
Q1 Productions to Host 4th Annual Pharmaceutical Sales Training and Development Conference This March
For the fourth consecutive year, Q1 Productions will host the annual Pharmaceutical Sales Training and Development Conference March 24-25 in Atlanta, fulfilling the marketplace demand for a more intimate and interactive, solution-generating meeting for sales training and development professionals.
Jubilant Biosys Announces Expansion of Drug Discovery Alliance with Janssen Pharmaceutica
Jubilant Biosys, a Bengaluru based subsidiary of Jubilant Life Sciences, announced today that it has expanded its drug discovery alliance with Janssen Pharmaceutica N.V., Beerse, Belgium.
NYSE Active Stock Watch List: Johnson & Johnson (NYSE:JNJ) and Best...
Growing Stock Report expands its NYSE Active Stock Watch List adding Johnson & Johnson and Best Buy Co., Inc. .
Johnson and Johnson, the brand's owner, recalled all the existing Tylenol, started a campaign to tell people not to take it, and, most important, fixed some key security problems.